Journals By Industry - Drug Design & Discovery

Peters brings more than 25 years of health care experience in marketing, market access and reimbursement, and business development positions. Most recently, Peters was vice president of US payers and national accounts, corporate...

The study has enrolled 41 patients who progressed on at least one prior chemotherapy regimen that included a platinum compound, or cisplatin, oxaliplatin, or carboplatin, and a fluoropyrimidine compound, or 5-fluorouracil [5-FU] or...

Eli Lilly and Co. is pouring more money than ever into its research and development pipeline, but Wall Street has been rewarding companies that cut such spending, according to a recent report by...

The head of the Food and Drug Administration's medical device unit stopped in San Diego last week for a series of one-on-one meetings with some of the area's largest device makers, including ResMed...

Last January Marc Alessi was tapped to lead the Long Island Angel Network as it sought to help finance startups that would hopefully grow to become the region's largest corporations. Now he has...

Marc Alessi is putting his money where his mouth is. The former state assemblymen turned executive director of the Long Island Angel Network, chairman of the Brookhaven Town Democratic Committee and counsel to...

PRINCETON, N.J. & WILMINGTON, Del. -- Bristol-Myers Squibb Company (NYSE: BMY) and AstraZeneca (NYSE: AZN) today announced that the U.S. Food and Drug Administration (FDA) has issued a complete response letter regarding the...

Stony Brook University has entered into a multiyear research partnership with the global pharmaceutical company Sanofi to develop a potential treatment for tuberculosis and other bacterial infections. The university didn't disclose the terms...

Pharmacogenetic Patents Have the Potential to Extend Drug Candidate's Potential Commercial Exclusivity Period If Regulatory Approval Obtained BROOMFIELD, Colo. -- ARCA biopharma, Inc. (Nasdaq:ABIO), a biopharmaceutical company developing genetically targeted therapies for cardiovascular...

CAMBRIDGE, Mass. -- Millennium: The Takeda Oncology Company today announced it has been named among the 100 Best Companies to Work For in the United States by FORTUNE. This is the second consecutive...

RESEARCH TRIANGLE PARK, N.C. -- BioCryst Pharmaceuticals, Inc., (NASDAQ:BCRX) today announced that Nancy J. Hutson, Ph.D. was elected to the Company's Board of Directors, effective Friday, January 20, 2012. "We are excited to...

NEEDHAM, Mass. -- Celldex Therapeutics, Inc. (Nasdaq: CLDX) today announced that it will host a research and development day for the investment community on Monday, January 23, 2012 at 8:30 am Eastern Time....

Standard Use of Rave by Japanese Specialty Pharma Across All Trials Will Streamline Research, Accelerate Decision Making and Help Expand Global Network NEW YORK & OSAKA, Japan -- Medidata Solutions (NASDAQ: MDSO), a...

FOSTER CITY, Calif. -- Gilead Sciences, Inc. (Nasdaq:GILD) today announced that Roy D. Baynes, MD, PhD, will join the company as Senior Vice President, Oncology Therapeutics. In this position, Dr. Baynes will report...

Developing therapeutics using novel biology to selectively activate genes CAMBRIDGE, Mass. -- RaNA Therapeutics, Inc. today announced it has completed a $20.7 million round of financing co-led by Atlas Venture, SR One, and...

Acquisition Reunites the McKernan Brothers--Noted Genomics Innovators and Pioneers WOBURN, Mass. -- Courtagen Life Sciences, Inc. ("Courtagen"), a privately held life sciences company that provides innovative proteomic and genomic products and services to...

ROCKVILLE, Md. -- Rexahn Pharmaceuticals, Inc. (NYSE Amex: RNN), a clinical stage pharmaceutical company developing and commercializing oncology and CNS therapeutics, today announced that it has secured Hungarian Regulatory Authority and Ethics Committee...

DUBLIN -- Research and Markets (http://www.researchandmarkets.com/research/01d4ba/global_diabetic_re) has announced the addition of the "Global Diabetic Retinopathy Drug Pipeline Capsule - 2012" report to their offering. Fore Pharma's latest report Global Diabetic Retinopathy Drug Pipeline...

DUBLIN -- Research and Markets (http://www.researchandmarkets.com/research/151583/vaccine_market_acc) has announced the addition of the "Vaccine Market Access in China - M&A paves the way for foreign companies" report to their offering. This report from Datamonitor...